×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio
Logo

Insider Transactions by Edward M. Kaye MD

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
STOKStoke Therapeutics, Inc.Edward M. Kaye MDDirectorAug 18, 2025Sale$18.2412,126221,154153,470Aug 20, 2025, 04:12 PM
STOKStoke Therapeutics, Inc.Edward M. Kaye MDDirectorAug 14, 2025Option/RSU Exercise-26,250-165,596Aug 18, 2025, 08:23 PM
CYTKCYTOKINETICS INCEdward M. Kaye MDDirectorJul 15, 2025Award/Grant$38.0132812,46729,986Jul 16, 2025, 05:43 PM
CYTKCYTOKINETICS INCEdward M. Kaye MDDirectorJun 05, 2025Sale$32.103,636116,71629,658Jun 05, 2025, 04:42 PM
CYTKCYTOKINETICS INCEdward M. Kaye MDDirectorApr 15, 2025Award/Grant$38.5632412,49325,961Apr 16, 2025, 04:05 PM
STOKStoke Therapeutics, Inc.Edward M. Kaye MDDirectorMar 19, 2025Sale$8.278,90773,661139,346Mar 20, 2025, 06:15 PM
STOKStoke Therapeutics, Inc.Edward M. Kaye MDDirectorMar 18, 2025Sale$8.6710,38290,012148,253Mar 20, 2025, 06:15 PM
CYTKCYTOKINETICS INCEdward M. Kaye MDDirectorJan 02, 2025Award/Grant$48.9325512,47725,637Jan 06, 2025, 04:25 PM
STOKStoke Therapeutics, Inc.Edward M. Kaye MDCEODec 30, 2024Option/RSU Exercise$0.6035,00021,00096,885Jan 02, 2025, 04:14 PM
STOKStoke Therapeutics, Inc.Edward M. Kaye MDCEODec 09, 2024Sale$12.996,78688,15861,885Dec 11, 2024, 04:04 PM
STOKStoke Therapeutics, Inc.Edward M. Kaye MDCEODec 06, 2024Sale$12.786,17078,83768,671Dec 10, 2024, 07:00 PM
STOKStoke Therapeutics, Inc.Edward M. Kaye MDCEODec 03, 2024Option/RSU Exercise-26,250-74,841Dec 10, 2024, 06:59 PM
STOKStoke Therapeutics, Inc.Edward M. Kaye MDCEODec 03, 2024Option/RSU Exercise-26,500-75,091Dec 05, 2024, 04:20 PM
STOKStoke Therapeutics, Inc.Edward M. Kaye MDCEODec 01, 2024Option/RSU Exercise-21,591-48,591Dec 03, 2024, 04:13 PM
CYTKCYTOKINETICS INCEdward M. Kaye MDDirectorOct 01, 2024Award/Grant$52.6023712,46625,382Oct 03, 2024, 05:26 PM
STOKStoke Therapeutics, Inc.Edward M. Kaye MDCEOMay 20, 2024Sale$15.4342,350653,52929,664May 22, 2024, 04:17 PM
STOKStoke Therapeutics, Inc.Edward M. Kaye MDCEOMar 15, 2024Option/RSU Exercise-35,500-80,500Mar 19, 2024, 08:30 PM
STOKStoke Therapeutics, Inc.Edward M. Kaye MDCEOMar 19, 2024Sale$6.1011,15067,99969,350Mar 19, 2024, 08:30 PM
CYTKCYTOKINETICS INCEdward M. Kaye MDDirectorJan 02, 2024Award/Grant$84.1214812,45019,317Jan 03, 2024, 04:23 PM
CYTKCYTOKINETICS INCEdward M. Kaye MDDirectorOct 02, 2023Award/Grant$27.8844812,49019,169Oct 03, 2023, 04:17 PM
STOKStoke Therapeutics, Inc.Edward M. Kaye MDCEOMar 27, 2023Option/RSU Exercise$0.6020,00012,00045,000Sep 08, 2023, 04:15 PM
CYTKCYTOKINETICS INCEdward M. Kaye MDDirectorApr 03, 2023Award/Grant$37.7129811,23813,347Apr 05, 2023, 04:08 PM
CYTKCYTOKINETICS INCEdward M. Kaye MDDirectorJan 03, 2023Award/Grant$44.3525311,22113,049Jan 04, 2023, 06:33 PM
CYTKCYTOKINETICS INCEdward M. Kaye MDDirectorOct 03, 2022Award/Grant$51.1122011,24412,796Oct 05, 2022, 04:21 PM
CYTKCYTOKINETICS INCEdward M. Kaye MDDirectorAug 05, 2022Option/RSU Exercise$8.7511,42899,99524,004Aug 08, 2022, 04:01 PM
CYTKCYTOKINETICS INCEdward M. Kaye MDDirectorAug 05, 2022Sale$50.0011,428571,40012,576Aug 08, 2022, 04:01 PM
CYTKCYTOKINETICS INCEdward M. Kaye MDDirectorJul 01, 2022Award/Grant$41.0027411,23412,576Jul 12, 2022, 04:22 PM
STOKStoke Therapeutics, Inc.Edward M. Kaye MDCEOMay 25, 2022Option/RSU Exercise$0.6015,0009,00025,000May 26, 2022, 05:16 PM
CYTKCYTOKINETICS INCEdward M. Kaye MDDirectorApr 01, 2022Award/Grant$38.3829311,2457,302Apr 01, 2022, 07:17 PM
CYTKCYTOKINETICS INCEdward M. Kaye MDDirectorDec 23, 2021Option/RSU Exercise$7.6115,000114,15021,765Dec 23, 2021, 07:11 PM
CYTKCYTOKINETICS INCEdward M. Kaye MDDirectorDec 23, 2021Sale$45.0015,000675,0006,765Dec 23, 2021, 07:11 PM
CYTKCYTOKINETICS INCEdward M. Kaye MDDirectorOct 01, 2021Award/Grant$36.7430611,2426,765Oct 04, 2021, 07:02 PM
CYTKCYTOKINETICS INCEdward M. Kaye MDDirectorJul 07, 2021Award/Grant$19.77631,2466,459Jul 08, 2021, 05:31 PM
CYTKCYTOKINETICS INCEdward M. Kaye MDDirectorJul 01, 2021Award/Grant$20.984769,9866,396Jul 02, 2021, 04:45 PM
CYTKCYTOKINETICS INCEdward M. Kaye MDDirectorApr 01, 2021Award/Grant$24.444099,996920Apr 05, 2021, 05:47 PM
CYTKCYTOKINETICS INCEdward M. Kaye MDDirectorJan 04, 2021Award/Grant$19.565119,995511Jan 05, 2021, 06:17 PM
STOKStoke Therapeutics, Inc.Edward M. Kaye MDCEODec 30, 2020Option/RSU Exercise$0.6010,0006,00010,000Jan 04, 2021, 06:33 PM
STOKStoke Therapeutics, Inc.Edward M. Kaye MDCEODec 17, 2020Sale$60.0019,8061,188,3605,194Dec 18, 2020, 09:07 PM
STOKStoke Therapeutics, Inc.Edward M. Kaye MDCEODec 18, 2020Sale$60.005,194311,6400Dec 18, 2020, 09:07 PM
STOKStoke Therapeutics, Inc.Edward M. Kaye MDCEONov 27, 2020Sale$50.0012,152607,60025,000Nov 30, 2020, 05:11 PM
STOKStoke Therapeutics, Inc.Edward M. Kaye MDCEONov 25, 2020Sale$50.0012,848642,40037,152Nov 25, 2020, 05:16 PM
CYTKCYTOKINETICS INCEdward M. Kaye MDDirectorOct 05, 2020Option/RSU Exercise$7.6120,000152,20020,000Oct 05, 2020, 08:38 PM
CYTKCYTOKINETICS INCEdward M. Kaye MDDirectorOct 05, 2020Sale$30.0020,000600,0000Oct 05, 2020, 08:38 PM
STOKStoke Therapeutics, Inc.Edward M. Kaye MDCEODec 16, 2019Option/RSU Exercise$0.6050,00030,00050,000Apr 15, 2020, 07:27 PM
SRPTSarepta Therapeutics, Inc.Edward M. Kaye MDDirectorAug 03, 2017Tax Payment (Shares)$37.8816,703632,71071,229Aug 07, 2017, 04:39 PM
SRPTSarepta Therapeutics, Inc.Edward M. Kaye MDDirectorAug 03, 2017Option/RSU Exercise-35,461-87,932Aug 07, 2017, 04:39 PM
SRPTSarepta Therapeutics, Inc.Edward M. Kaye MDDirectorJul 20, 2017Tax Payment (Shares)$40.934,349178,00562,471Jul 21, 2017, 09:48 PM
SRPTSarepta Therapeutics, Inc.Edward M. Kaye MDDirectorJul 20, 2017Sale$41.0010,000410,00052,471Jul 21, 2017, 09:48 PM
SRPTSarepta Therapeutics, Inc.Edward M. Kaye MDPresident & CEOApr 20, 2017Tax Payment (Shares)$32.544,349141,51666,820Apr 24, 2017, 05:11 PM
SRPTSarepta Therapeutics, Inc.Edward M. Kaye MDPresident, CEO & CMOJan 20, 2017Tax Payment (Shares)$32.664,466145,86071,169Jan 24, 2017, 05:52 PM
SRPTSarepta Therapeutics, Inc.Edward M. Kaye MDPresident, CEO & CMONov 09, 2016Option/RSU Exercise$8.283,00024,84075,635Nov 10, 2016, 08:19 AM
SRPTSarepta Therapeutics, Inc.Edward M. Kaye MDPresident, CEO & CMOOct 20, 2016Tax Payment (Shares)$49.054,348213,26972,635Oct 24, 2016, 04:33 PM
SRPTSarepta Therapeutics, Inc.Edward M. Kaye MDPresident, CEO & CMOSep 22, 2016Sale$60.0040,1792,410,74076,983Sep 26, 2016, 04:23 PM
SRPTSarepta Therapeutics, Inc.Edward M. Kaye MDPresident, CEO & CMOSep 22, 2016Option/RSU Exercise$8.2840,179332,682117,162Sep 26, 2016, 04:23 PM
SRPTSarepta Therapeutics, Inc.Edward M. Kaye MDPresident, CEO & CMOSep 19, 2016Option/RSU Exercise$6.9424,352168,94189,983Sep 21, 2016, 09:29 PM
SRPTSarepta Therapeutics, Inc.Edward M. Kaye MDPresident, CEO & CMOSep 19, 2016Sale$50.0024,3521,217,60076,983Sep 21, 2016, 09:29 PM
SRPTSarepta Therapeutics, Inc.Edward M. Kaye MDSVP Interim CEO & CMOSep 14, 2016Sale$30.0024,557736,71076,983Sep 16, 2016, 04:04 PM
SRPTSarepta Therapeutics, Inc.Edward M. Kaye MDSVP Interim CEO & CMOAug 31, 2016Tax Payment (Shares)$26.071,48738,766101,540Sep 02, 2016, 04:43 PM
SRPTSarepta Therapeutics, Inc.Edward M. Kaye MDSVP Interim CEO & CMOJul 20, 2016Tax Payment (Shares)$22.463,00167,402103,027Jul 22, 2016, 05:20 PM
SRPTSarepta Therapeutics, Inc.Edward M. Kaye MDSVP Interim CEO & CMOApr 20, 2016Tax Payment (Shares)$19.713,00159,150106,028Apr 22, 2016, 04:36 PM
SRPTSarepta Therapeutics, Inc.Edward M. Kaye MDSVP Interim CEO & CMOJan 20, 2016Tax Payment (Shares)$13.263,36844,660103,525Jan 25, 2016, 01:28 PM
SRPTSarepta Therapeutics, Inc.Edward M. Kaye MDSVP Interim CEO & CMOOct 20, 2015Tax Payment (Shares)$26.743,00180,247106,893Oct 22, 2015, 06:24 PM
SRPTSarepta Therapeutics, Inc.Edward M. Kaye MDSVP Interim CEO & CMOJul 20, 2015Tax Payment (Shares)$33.483,000100,440109,094Jul 31, 2015, 04:36 PM
SRPTSarepta Therapeutics, Inc.Edward M. Kaye MDSVP & Chief Medical OfficerFeb 27, 2015Buy$11.818009,4521,311Mar 03, 2015, 06:48 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe